NBG-030

N/A

Report date: 2023/08/29 17:45:58

Base Information

Drug NameNBG-030
Drug Alias NameNBG-030NBG030
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionFrizzled receptors antagonists
TargetsFrizzled receptors
Therapy Area/IndicationsFibrosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNB Health Laboratory Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsFibrosisNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A